PubMed COVID-19 Clinical Care
2911 - 2920 of 3242 results found
Shifting age of child eating disorder hospitalizations during the Covid-19 pandemic
Description
CONCLUSIONS: The Covid-19 pandemic affected hospitalizations for anorexia nervosa as well as other eating disorders, beginning with girls aged 10-14 years during wave 1, followed by girls aged 15-19 years during wave 2. Boys aged 10-14 years were
Stochastic analysis of a COVID-19 model with effects of vaccination and different transition rates: Real data approach
Description
This paper presents a stochastic model for COVID-19 that takes into account factors such as incubation times, vaccine effectiveness, and quarantine periods in the spread of the virus in symptomatically contagious populations. The paper outlines the
Strict Lockdown versus Flexible Social Distance Strategy for COVID-19 Disease: a Cost-Effectiveness Analysis
Description
CONCLUSIONS: Comparisons of public health interventions for COVID-19 should take into account life years saved and not only lost lives. Strict lockdown costs more than US$ 130,000 per life year saved. As our all our assumptions were in favour of
Spontaneous pneumomediastinum after BNT162b2 COVID-19 vaccination in adolescents
Description
No abstract
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associat...
Description
INTRODUCTION: Sepsis, the leading cause of acute kidney injury (AKI), is associated with a high morbidity and mortality. Alkaline phosphatase (ALP) is an endogenous detoxifying enzyme. A recombinant human ALP compound, ilofotase alfa, showed no
Severe acute respiratory syndrome coronavirus-2 accessory proteins ORF3a and ORF7a modulate autophagic flux and Ca2+ homeostasis in yeast
Description
Virus infection involves the manipulation of key host cell functions by specialized virulence proteins. The Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) small accessory proteins ORF3a and ORF7a have been implicated in favoring virus
Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variant
Description
No abstract
Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines
Description
CONCLUSION: The findings showed that high doses of current MERS-CoV vaccine candidates conferred better immunogenicity than low doses and that there were no differences in the safety of the vaccines.
SARS-CoV-2 reinfection with different SARS-CoV-2 variants in children, Ohio, US
Description
CONCLUSION: As SARS-CoV-2 continues to evolve, there is a need for ongoing surveillance to identify the frequency and time interval between reinfections and to re-evaluate the definition of SARS-CoV-2 reinfections.
